400
Participants
Start Date
March 15, 2021
Primary Completion Date
December 18, 2022
Study Completion Date
December 18, 2022
artemether lumefantrine
The drugs are approved and in use by the Kenya Ministry of Health as the 1st and 2nd line treatment for malaria. The study is to assess the continued efficacy of the two drugs in the treatment of uncomplicated malaria.
dihydroartemisinin piperaquine
Antimalarial Combinations
Makhonge Health Centre, Bungoma
Kaluo Health Centre, Siaya
Kenya Ministry of Health
OTHER_GOV
Centers for Disease Control and Prevention
FED
United States Agency for International Development (USAID)
FED
Jhpiego
OTHER